Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Changes in Stockholders??? Equity (Deficit)

v3.26.1
Consolidated Statements of Changes in Stockholders’ Equity (Deficit) - USD ($)
Total
Common Stock [Member]
Treasury Stock, Common [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Other Comprehensive Loss [Member]
Beginning balance, value at Dec. 31, 2023 $ (11,457,000) $ (502,000) $ 292,467,000 $ (303,004,000) $ (418,000)
Beginning balance, shares at Dec. 31, 2023   3,861,578        
Beginning balance, treasury stock, shares at Dec. 31, 2023     (10,130)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Release of restricted stock  
Release of restricted stock, shares   119,765        
Issuance of common stock in lieu of cash bonus and consulting fees 35,000 35,000  
Issuance of common stock in lieu of cash bonus and consulting fees, shares   11,453        
Common stock issued upon conversion of 2022 Promissory Note 4,505,000 4,505,000  
Common stock issued upon conversion of 2022 Promissory Note, shares   336,550        
Sales of common stock, net of issuance costs 122,342,000 $ 2,000 122,340,000  
Sales of common stock, net of issuance costs, shares   15,695,688        
Fractional share issuances as a result of reverse stock split  
Fractional share issuances as a result of reverse stock split, shares   141,631        
Stock-based compensation expense 1,656,000 1,656,000  
Loss on disposal of subsidiaries 418,000   $ 418,000
Net Income (Loss) (10,316,000) (10,316,000)  
Ending balance, value at Dec. 31, 2024 $ 107,183,000 $ 2,000 $ (502,000) 421,003,000 (313,320,000)  
Ending balance, shares at Dec. 31, 2024 20,156,535 20,166,665        
Ending balance, treasury stock, shares at Dec. 31, 2024     (10,130)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Release of restricted stock  
Release of restricted stock, shares   17,415        
Common stock issued upon conversion of 2022 Promissory Note 0          
Sales of common stock, net of issuance costs 80,000 80,000  
Sales of common stock, net of issuance costs, shares   14,210        
Stock-based compensation expense 455,000   455,000  
Net Income (Loss) (11,401,000) (11,401,000)  
Ending balance, value at Dec. 31, 2025 $ 96,317,000 $ (502) $ 421,538,000 $ (324,721,000)  
Ending balance, shares at Dec. 31, 2025 20,188,160 20,198,290        
Ending balance, treasury stock, shares at Dec. 31, 2025     (10,130)